Technology News and Research

RSS

Researchers investigate new digital tool for breast cancer prognosis

Cancer researchers at the University of Calgary are investigating a new tool to use for the prognosis of breast cancer in patients. This new digital tool will help give patients a more accurate assessment of how abnormal and aggressive their cancer is and help doctors recommend the best treatment options.

19 Apr 2011

Avvo provides five tips for physicians to manage their career online

Avvo, the world's largest online directory for doctors and lawyers that provides free rankings for 90% of the working physicians in the U.S., offers five tips for physicians who are hesitant, because of perceived HIPAA restrictions, to embrace online and social media marketing. Avvo, which was founded to service the legal sector, is no stranger to the impact of regulatory issues on the healthcare industry.

19 Apr 2011

Groundbreaking news on Dengue

Daily temperature fluctuations, not just high temperatures, play a significant role in the transmission of dengue, a deadly mosquito-borne disease that strikes millions of people in tropical and subtropical countries, according to ground-breaking research led by French, Thailand and U.S. scientists and conceived by medical entomologist Thomas Scott of the University of California, Davis.

18 Apr 2011

Nathan Littauer Hospital selects ProVation Order Sets to deliver safe and high-quality care

Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Nathan Littauer Hospital has selected ProVation® Order Sets, powered by UpToDate® Decision Support, as the hospital's electronic order set solution.

18 Apr 2011

Rural health providers get IT shopping tips

Medical providers, especially those in rural and small offices, who are shopping for an electronic health record vendor should consider the issue of data portability before making a decision, said David Blumenthal, who until this spring was the national coordinator for health information technology.

18 Apr 2011

MRO announces Keystone acquisition

MRO Corp., a leading provider of disclosure management applications and services for healthcare organizations, today announced that it has acquired the assets of Keystone Management Solutions, a provider of release of information services based in Malvern, Pennsylvania. This acquisition will enable MRO to continue building its market presence across Pennsylvania, Massachusetts and Louisiana, where Keystone Management Solutions currently serves hospitals and health systems.

18 Apr 2011

Bio-IT World honors CliniWorks with 2011 Best Practices Award

CliniWorks Inc., developer of the AccelFind™ clinical evidence and research-acceleration software platform, announced that it received the prestigious Judge's Choice Award in Bio-IT World's 2011 Best Practices Award competition. The Award was received by CliniWorks founders Nitzan Sneh and Udi Meirav in front of a standing-room-only audience at the Boston World Trade Center on April 13, 2011.

18 Apr 2011

Symphony Technology Group acquires ImpactRx

ImpactRx, the pioneer in measuring the impact of promotion on physician prescribing behavior, announced today that Symphony Technology Group (STG), has acquired a majority ownership interest in the Company. STG is a leading private equity firm with a strategic focus on data, analytics and technology-enabled services companies. Merck Capital Ventures (MCV), the venture capital arm of Merck and one of ImpactRx's existing investors, will maintain its investment in ImpactRx.

18 Apr 2011

Double Eagle acquires Fuse Science

Double Eagle Holdings, Ltd. announced today that it has successfully completed the acquisition of Fuse Science, Inc. Under the terms of the acquisition agreement, Fuse Science becomes a wholly-owned subsidiary of Double Eagle, effectively repositioning Double Eagle as an innovation-based consumer products holding company.

18 Apr 2011

QHR to connect over 72 physicians to AccuroEMR

QHR Technologies Inc., a leading Canadian Healthcare technology provider announced that its Electronic Medical Records (EMR) division, Optimed Software Corporation, will connect over 700 users including 72 physicians, in the community of Barrie, Ontario to its Accuro®EMR, creating the largest integrated healthcare network in Canada using one EMR software.

18 Apr 2011

Ahram Biosystems launches portable Palm PCR thermocycler system

Ahram Biosystems, Inc., a leading innovator of new life science tools, today announced the launch of the Palm PCR system, an innovative portable PCR device that delivers high performance nucleic acid amplification in a small handheld format.

18 Apr 2011

CoDa Therapeutics raises $19.2 million in Series B financing

CoDa Therapeutics, Inc. announced today that it has raised $19.2 million in a Series B financing. Current investors Domain Associates, GBS Venture Partners and BioPacificVentures participated in the round. The company expects further Series B financing with participation from additional investors in a second closing, scheduled for a future date.

18 Apr 2011

Baxter enters definitive agreement to acquire Prism

Baxter International Inc. announced today that it has entered into a definitive agreement to acquire privately-held Prism Pharmaceuticals, Inc., a specialty pharmaceutical company based in King of Prussia, PA. Prism Pharmaceuticals has developed and received U.S. Food and Drug Administration (FDA) approval for multiple presentations of NEXTERONE® (amiodarone HCl), an antiarrhythmic agent.

From Baxter International Inc. 18 Apr 2011

St. Jude Medical's Accent MRI pacemaker and Tendril MRI lead system receives European CE Mark approval

St. Jude Medical, Inc., a global medical device company, today announced that it has received European CE Mark approval for its Accent MRI™ pacemaker and Tendril MRI™ lead. The system, designed and tested for safe use in a Magnetic Resonance Imaging (MRI) environment and approved as MR-Conditional, allows patients to undergo full-body, high-resolution MRI scans.

18 Apr 2011

Idera's gene-silencing oligonucleotide studies published in Journal of Medicinal Chemistry

Idera Pharmaceuticals, Inc. today announced the online publication in the Journal of Medicinal Chemistry of its studies of a novel class of compounds, which we refer to as gene-silencing oligonucleotides.

18 Apr 2011

iOWH's semisynthetic ART enters production, distribution phase to combat malaria

The Institute for OneWorld Health, a non-profit drug development organization, announced today that its development of an alternative source of artemisinin using pioneering synthetic biology technology has successfully entered the production and distribution phase.

18 Apr 2011

Nuvo Research to acquire ZARS Pharma

Nuvo Research Inc., a pharmaceutical company dedicated to building a portfolio of products primarily for the treatment of pain, today announced that it has entered into an agreement to acquire ZARS Pharma, Inc., a specialty pharmaceutical company based in Salt Lake City, Utah.

18 Apr 2011

Transgene, Inovio and ChronTech collaborate for novel vaccine phase I trial in HCV

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today it has signed a collaboration agreement with Transgene S.A. and ChronTech Pharma AB to evaluate a novel therapeutic vaccination strategy against genotype 1 hepatitis C virus in a phase I clinical study.

18 Apr 2011

CMS offers cash to aid states in care coordination for 'dual eligibles'

The Centers for Medicare and Medicaid services announced four initiatives Thursday that are designed to assist cash-strapped states with funding and flexibility issues.

16 Apr 2011

Team of researchers study development of mesoderm

During the development of an embryo, a large number of different, specialised cell-types arise from the fertilised egg. The genetic information is identical in all cells of an organism. Different properties of cells arise because the activity of genes is controlled and regulated by so called transcription factors. By switching genes on or off, the body makes muscle cells, bone cells, liver cells and many more.

16 Apr 2011